D.E. Shaw & Co
CORZ icon

D.E. Shaw & Co’s Core Scientific CORZ Stock Holding History

D.E. Shaw & Co’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$918K Sell
61,333
-167,211
-73% -$2.85M ﹤0.01% 3495
2025
Q4 		$3.33M Sell
228,544
-4,809,906
-95% -$83.9M ﹤0.01% 2646
2025
Q3 		$90.4M Buy
5,038,450
+439,826
+10% +$6.45M 0.05% 430
2025
Q2 		$78.5M Buy
4,598,624
+1,748,662
+61% +$17.5M 0.06% 398
2025
Q1 		$20.6M Buy
2,849,962
+2,154,292
+310% +$24.5M 0.02% 928
2024
Q4 		$9.77M Buy
+695,670
New +$10.3M 0.01% 1519

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

D.E. Shaw & Co's CORZ Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Core Scientific (CORZ) stake by 73% in Q1 2026, selling an estimated $2.85M and leaving 61,333 shares worth $918K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

D.E. Shaw & Co first reported a position in CORZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $90.4M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • D.E. Shaw & Co held 61,333 shares of Core Scientific worth $918K as of Q1 2026.
  • D.E. Shaw & Co sold 167,211 Core Scientific shares in Q1 2026, an estimated $2.85M.
  • Core Scientific made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3495 holding.
  • D.E. Shaw & Co first reported a position in Core Scientific in Q4 2024 and has held it in 6 quarters since.
  • D.E. Shaw & Co's Core Scientific position peaked at $90.4M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.